Jackman Rachael P, Thomas Kimberly A
Vitalant Research Institute.
Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California.
Curr Opin Hematol. 2025 Jul 15. doi: 10.1097/MOH.0000000000000888.
Platelet transfusion can have a significant immunological impact, exposing the recipient to alloantigens on the surface of platelets and contaminating leukocytes, a dynamic range of soluble immune mediators, and donor platelets that can directly and indirectly contribute to the inflammatory profile of the recipient. Here, we will review recent developments in our understanding of the mechanisms regulating the immune response to platelet transfusion.
Using animal models, much has been learned about the mechanisms regulating the alloimmune response to platelet transfusion and how this response is shaped by the underlying health of the recipient. There is also a growing appreciation of the active role platelets play in immunity and their impact on the recipient immune system and transfusion outcomes, and how these immunological profiles are shaped by product collection, processing, and storage practices.
While platelet transfusion carries significant benefit to a wide range of patients, it carries risk of alloimmunization and other immune-mediated adverse reactions. Further characterization of the mechanisms regulating these outcomes can lead to new interventions to prevent alloimmunization and help to identify which platelet products are best suited to different patient populations.
血小板输注可产生显著的免疫影响,使受者接触血小板表面的同种异体抗原以及污染的白细胞、一系列可溶性免疫介质,以及可直接和间接影响受者炎症状态的供体血小板。在此,我们将综述近期在理解调节血小板输注免疫反应机制方面的进展。
利用动物模型,我们对调节血小板输注同种免疫反应的机制以及该反应如何受受者基础健康状况影响有了很多了解。人们也越来越认识到血小板在免疫中所起的积极作用及其对受者免疫系统和输血结果的影响,以及这些免疫特征如何受产品采集、处理和储存方式的影响。
虽然血小板输注对广泛的患者有显著益处,但它存在同种免疫和其他免疫介导不良反应的风险。对调节这些结果的机制进行进一步表征可带来预防同种免疫的新干预措施,并有助于确定哪些血小板产品最适合不同患者群体。